Eli Lilly And Co vs TotalEnergies SE — how do they compare? Eli Lilly And Co trades at $1,220.99 (market cap $1.08T), while TotalEnergies SE trades at $86.9 (market cap $196.06B). The key difference: Eli Lilly And Co is far larger — about 5.5× TotalEnergies SE's market cap, and TotalEnergies SE pays the higher dividend (4.82%). Which is the better fit depends on your goals.
| LLY | TTE | |
|---|---|---|
Market Cap | $1.08T | $196.06B |
Sector | Health | Energy |
52-Week High | $1.24K | $93.60 |
52-Week Low | $639.43 | $57.39 |
Enterprise Value | $1.13T | $227.06B |
Dividend Yield | 0.57% | 4.82% |
Signals from Pluang's Aura AI — not financial advice
Eli Lilly (LLY) trades at $1,223.97, down 0.62% on the day, maintaining strong bullish momentum with consecutive earnings beats and robust revenue growth. The stock shows technical strength above key support levels at $1,207, while fundamentals reveal exceptional profitability with 33.53% net margins and 102.44% ROE. Recent quarterly results exceeded expectations, with Q2 2026 revenue surging 48% to $23 billion driven by Mounjaro and Zepbound demand.
Outlook remains positive with analyst consensus targeting $1,380 and 73% buy ratings, though elevated valuations (P/E 40.8) and regulatory risks around weight-loss drug competition present headwinds. The company's pipeline advancement with retatrutide filing expected in 2027 provides medium-term growth catalysts, but investors should monitor execution risks in the competitive obesity drug market.
TotalEnergies (TTE) trades at $87.46, down 0.57% on the day, with a bullish technical signal and strong analyst consensus. Recent earnings show mixed quarterly beats, while revenue declined to $182.34B in 2025. The company is expanding in renewables, acquiring Shell's European onshore renewables business and partnering on a Cyprus gas field development.
TTE offers value with a P/E of 11.01 and a 57.58% buy rating from analysts, targeting $94.00. Risks include declining revenue trends, legal challenges from climate litigation, and oil price volatility. The stock presents a balanced opportunity with income from dividends but faces execution risks in energy transition.
Trailing returns across standard periods
Latest headlines on both assets
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →TotalEnergies is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2021, it produced 1.5 million barrels of liquids and 7.2 billion cubic feet of natural gas per day. At year-end 2020, reserves stood at 12.1 billion barrels of oil equivalent, 45% of which are liquids. During 2021, it had LNG sales of 42 Mt. The company owns interests in refineries with capacity of nearly 1.8 million barrels a day, primarily in Europe, distributes refined products in 65 countries, and manufactures commodity and specialty chemicals. It also holds a 19% interest in Russian oil company Novatek. At year-end, its gross installed renewable power generation capacity was 10.3 GW.
Read more on TTE →